40 results on '"Sparano, Joseph A"'
Search Results
2. Racial disparities in neutrophil counts among patients with metastatic breast cancer during treatment with CDK4/6 inhibitors
3. Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
4. Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance)
5. A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104)
6. Primary Central Nervous System Lymphoma
7. Special Considerations Regarding Antiretroviral Therapy and Infection Prophylaxis in the HIV-Infected Individual with Cancer
8. A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer
9. Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach
10. Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103
11. Increasing the Efficacy of 5-Fluorouracil with Interferons: Preclinical, Clinical, and Pharmacokinetic Studies
12. Clinical Studies Examining the Impact of Obesity on Breast Cancer Risk and Prognosis
13. Phase I–II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin–cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma
14. Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy
15. Mitotic counts in breast cancer after neoadjuvant systemic chemotherapy and development of metastatic disease
16. TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer
17. Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study
18. A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103)
19. GRB7 is required for triple-negative breast cancer cell invasion and survival
20. Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies
21. Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group Trial E3198
22. Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy
23. A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial
24. Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualization
25. Is there a role for ovarian function suppression in operable breast cancer?
26. Primary Central Nervous System Lymphoma
27. Special Considerations Regarding Antiretroviral Therapy and Infection Prophylaxis in the HIV-Infected Individual with Cancer
28. Hodgkin’s Disease: Clinical Presentation and Treatment
29. Treatment of Kaposis Sarcoma
30. Biology of Non-Hodgkin’s Lymphoma
31. The Biology of Kaposi’s Sarcoma
32. AIDS Malignancy Clinical Research: Resources of the National Cancer Institute
33. Non-Hodgkin’s Lymphoma: Pathogenesis, Clinical Presentation, and Treatment
34. HTLV-I Associated Leukemia/Lymphoma: Epidemiology, Biology, and Treatment
35. Immunopathogenesis of HIV and HTLV-1 Infection: Mechanisms for Lymphomagenesis
36. Hematopoiesis in HIV Infection: Use of Colony Stimulating Factors and Cytokines
37. Epidemiology of HIV-Associated Malignancies
38. Biology of Anogenital Neoplasia
39. Non-AIDS-Defining Malignancies
40. Management of Cervical Neoplasia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.